16155-08-1,MFCD00215725
Catalog No.:AA001VLU

16155-08-1 | 1-Benzyl-4-(4-nitrophenyl)piperazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$75.00   $53.00
- +
5g
98%
in stock  
$194.00   $136.00
- +
10g
98%
in stock  
$281.00   $197.00
- +
25g
98%
in stock  
$583.00 $408.00
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001VLU
Chemical Name:
1-Benzyl-4-(4-nitrophenyl)piperazine
CAS Number:
16155-08-1
Molecular Formula:
C17H19N3O2
Molecular Weight:
297.3517
MDL Number:
MFCD00215725
SMILES:
[O-][N+](=O)c1ccc(cc1)N1CCN(CC1)Cc1ccccc1
Properties
Properties
 
BP:
461.7°C at 760 mmHg  
Form:
Solid  
MP:
112 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
349  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.2  

Upstream Synthesis Route

[1]BritishJournalofPharmacology,2018,vol.175,#12,p.2399-2413

[2]EuropeanJournalofOrganicChemistry,2001,#16,p.3105-3118

[3]JournalofMedicinalChemistry,2005,vol.48,#26,p.8261-8269

[4]Patent:WO2005/7625,2005,A2,.Locationinpatent:Page61

[5]BioorganicandMedicinalChemistryLetters,2015,vol.25,#5,p.1092-1099

[6]Patent:US2004/167122,2004,A1,.Locationinpatent:Page/Pagecolumn12

[7]Patent:US4906634,1990,A,

[8]Patent:US5051423,1991,A,

[9]Patent:US2005/222408,2005,A1,

[10]ArchivesofPharmacalResearch,2016,vol.39,#5,p.603-617

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2005,vol.44,#7,p.1515-1518

[2]Patent:US2003/96828,2003,A1,

[1]Patent:WO2009/130481,2009,A1,.Locationinpatent:Page/Pagecolumn136-137

[1]Arzneimittel-Forschung/DrugResearch,2005,vol.55,#3,p.145-152

[1]Patent:US5086055,1992,A,

Downstream Synthesis Route

[1]BritishJournalofPharmacology,2018,vol.175,p.2399-2413

[2]EuropeanJournalofOrganicChemistry,2001,p.3105-3118

[3]JournalofMedicinalChemistry,2005,vol.48,p.8261-8269

[4]Patent:WO2005/7625,2005,A2.Locationinpatent:Page61

[5]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.1092-1099

[6]Patent:US2004/167122,2004,A1.Locationinpatent:Page/Pagecolumn12

[7]Patent:US4906634,1990,A

[8]Patent:US5051423,1991,A

[9]Patent:US2005/222408,2005,A1

[10]ArchivesofPharmacalResearch,2016,vol.39,p.603-617

[1]Patent:US2004/167122,2004,A1.Locationinpatent:Page/Pagecolumn12-13

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:16155-08-1 Molecular Formula|16155-08-1 MDL|16155-08-1 SMILES|16155-08-1 1-Benzyl-4-(4-nitrophenyl)piperazine
Catalog No.: AA001VLU
16155-08-1,MFCD00215725
16155-08-1 | 1-Benzyl-4-(4-nitrophenyl)piperazine
Pack Size: 1g
Purity: 98%
in stock
$75.00 $53.00
Pack Size: 5g
Purity: 98%
in stock
$194.00 $136.00
Pack Size: 10g
Purity: 98%
in stock
$281.00 $197.00
Pack Size: 25g
Purity: 98%
in stock
$583.00 $408.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001VLU
Chemical Name: 1-Benzyl-4-(4-nitrophenyl)piperazine
CAS Number: 16155-08-1
Molecular Formula: C17H19N3O2
Molecular Weight: 297.3517
MDL Number: MFCD00215725
SMILES: [O-][N+](=O)c1ccc(cc1)N1CCN(CC1)Cc1ccccc1
Properties
BP: 461.7°C at 760 mmHg  
Form: Solid  
MP: 112 °C  
Storage: Keep in dry area;Room Temperature;  
Complexity: 349  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 22  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.2  
Upstream Synthesis Route
2759-28-6    350-46-9    16155-08-1 

[1]BritishJournalofPharmacology,2018,vol.175,#12,p.2399-2413

[2]EuropeanJournalofOrganicChemistry,2001,#16,p.3105-3118

[3]JournalofMedicinalChemistry,2005,vol.48,#26,p.8261-8269

[4]Patent:WO2005/7625,2005,A2,.Locationinpatent:Page61

[5]BioorganicandMedicinalChemistryLetters,2015,vol.25,#5,p.1092-1099

[6]Patent:US2004/167122,2004,A1,.Locationinpatent:Page/Pagecolumn12

[7]Patent:US4906634,1990,A,

[8]Patent:US5051423,1991,A,

[9]Patent:US2005/222408,2005,A1,

[10]ArchivesofPharmacalResearch,2016,vol.39,#5,p.603-617

2759-28-6    100-00-5    16155-08-1 

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2005,vol.44,#7,p.1515-1518

[2]Patent:US2003/96828,2003,A1,

6269-89-2    100-39-0    16155-08-1 

[1]Patent:WO2009/130481,2009,A1,.Locationinpatent:Page/Pagecolumn136-137

6269-89-2    100-44-7    16155-08-1 

[1]Arzneimittel-Forschung/DrugResearch,2005,vol.55,#3,p.145-152

2759-28-6    350-46-9    16155-08-1 

[1]Patent:US5086055,1992,A,

Downstream Synthesis Route
2759-28-6    350-46-9    16155-08-1 

[1]BritishJournalofPharmacology,2018,vol.175,p.2399-2413

[2]EuropeanJournalofOrganicChemistry,2001,p.3105-3118

[3]JournalofMedicinalChemistry,2005,vol.48,p.8261-8269

[4]Patent:WO2005/7625,2005,A2.Locationinpatent:Page61

[5]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.1092-1099

[6]Patent:US2004/167122,2004,A1.Locationinpatent:Page/Pagecolumn12

[7]Patent:US4906634,1990,A

[8]Patent:US5051423,1991,A

[9]Patent:US2005/222408,2005,A1

[10]ArchivesofPharmacalResearch,2016,vol.39,p.603-617

7205-98-3    16155-08-1    744218-37-9 

[1]Patent:US2004/167122,2004,A1.Locationinpatent:Page/Pagecolumn12-13

Building Blocks More >
161877-70-9
161877-70-9
L-Valinamide, N-[4-[[4-(dimethylamino)phenyl]azo]benzoyl]-L-tyrosyl-L-valyl-L-alanyl-L-α-aspartyl-L-alanyl-L-prolyl-N-[2-[(5-sulfo-1-naphthalenyl)amino]ethyl]- (9CI)
AA001VVJ | MFCD01076565
16554-45-3
16554-45-3
2-Methoxy-6-nitro-phenylamine
AA001W5D | MFCD01930197
16606-55-6
16606-55-6
(R)-(+)-Propylene carbonate
AA001WEU | MFCD00798265
16642-79-8
16642-79-8
3-(4-Nitrophenyl)propanoic acid
AA001WNQ | MFCD00126834
16691-79-5
16691-79-5
Dimethyl 2-oxo-4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate
AA001WXZ | MFCD00111095
16732-64-2
16732-64-2
4-Bromo-1H-indole-2-carboxylic acid
AA001X83 | MFCD21607478
167710-69-2
167710-69-2
Ethyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride
AA001XH6 | MFCD13152194
168141-99-9
168141-99-9
4-Hydroxyquinoline-2-carbaldehyde
AA001XSQ | MFCD06408352
16859-51-1
16859-51-1
L-Phenylalanine, N-(1-oxopentyl)-
AA001Y3F | MFCD09811748
16903-61-0
16903-61-0
Copper, [tetrahydroborato(1-)-κH,κH']bis(triphenylphosphine)-, (T-4)-
AA001YCO | MFCD00013219
Submit
© 2017 AA BLOCKS, INC. All rights reserved.